(Q46640318)

23 December 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Disruption of the Bcr-Abl/Hsp90 protein complex: a possible mechanism to inhibit Bcr-Abl-positive human leukemic blasts by novobiocin (English)

1 reference

23 December 2017

main subject

novobiocin

1 reference

ChEBI release 2020-05-28

1 reference

L X Wu

1

1 reference

23 December 2017

J H Xu

2

1 reference

23 December 2017

K Z Zhang

3

1 reference

23 December 2017

Q Lin

4

1 reference

23 December 2017

X W Huang

5

1 reference

23 December 2017

C X Wen

6

1 reference

23 December 2017

Y Z Chen

7

1 reference

23 December 2017

publication date

17 April 2008

1 reference

23 December 2017

published in

Leukemia

1 reference

23 December 2017

volume

22

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

page(s)

1402-1409

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/leu.2008.89

exact match

0 references

cites work

Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

ATP-binding properties of human Hsp90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

Two chaperone sites in Hsp90 differing in substrate specificity and ATP dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

Modulation of chaperone function and cochaperone interaction by novobiocin in the C-terminal domain of Hsp90: evidence that coumarin antibiotics disrupt Hsp90 dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

Chronic myelogenous leukemia: biology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

Beauvericin induces cytotoxic effects in human acute lymphoblastic leukemia cells through cytochrome c release, caspase 3 activation: the causative role of calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

Down-regulation of p210(bcr/abl) by curcumin involves disrupting molecular chaperone functions of Hsp90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

Detection of dead cells and measurement of cell killing by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

Mechanistic role of heat shock protein 70 in Bcr-Abl-mediated resistance to apoptosis in human acute leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

Hop modulates Hsp70/Hsp90 interactions in protein folding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

Steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

Novobiocin: redesigning a DNA gyrase inhibitor for selective inhibition of hsp90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

p185erbB2 binds to GRP94 in vivo. Dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

7 January 2021

The importance of ATP binding and hydrolysis by hsp90 in formation and function of protein heterocomplexes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

7 January 2021

Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

7 January 2021

Anomalous expression of the HLA-DR alpha and beta chains in ovarian and other cancers

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.89

7 January 2021

Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins hsp90 and hsp70

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1038/LEU.2008.89

Identifiers

DOI

10.1038/LEU.2008.89

1 reference

23 December 2017

release_lxig4wdofzcgziub6xtlshht3m

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lxig4wdofzcgziub6xtlshht3m

24 November 2022

mapped directly with Wikidata item

1 reference

23 December 2017